These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6629590)
1. Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. Romani L; Migliorati G; Bonmassar E; Fioretti MC Int J Immunopharmacol; 1983; 5(4):299-306. PubMed ID: 6629590 [TBL] [Abstract][Full Text] [Related]
2. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. Migliorati G; Romani L; Fioretti MC Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118 [TBL] [Abstract][Full Text] [Related]
3. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. Romani L; Fioretti MC; Bonmassar E Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379 [TBL] [Abstract][Full Text] [Related]
4. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline. Testorelli C; Archetti YL; Aresca P; Del Vecchio L Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006 [TBL] [Abstract][Full Text] [Related]
6. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells. Campanile F; Iorio AM; Bonmassar E Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192 [TBL] [Abstract][Full Text] [Related]
7. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies. Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. Fioretti MC; Bianchi R; Romani L; Bonmassar E J Natl Cancer Inst; 1983 Dec; 71(6):1247-51. PubMed ID: 6581361 [TBL] [Abstract][Full Text] [Related]
9. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas. Testorelli C; Franco P; Goldin A; Nicolin A Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062 [TBL] [Abstract][Full Text] [Related]
10. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
11. Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound. Giampietri A; Fioretti MC; Goldin A; Bonmassar E J Natl Cancer Inst; 1980 Feb; 64(2):297-301. PubMed ID: 6928222 [TBL] [Abstract][Full Text] [Related]
12. Macrophage antitumor activity induced by the antigenic lymphoma L5178Y/DTIC subline. Marelli O; Mantovani A; Franco P; Nicolin A Tumori; 1982 Oct; 68(5):365-71. PubMed ID: 7179493 [TBL] [Abstract][Full Text] [Related]
13. RNK granule extract cytolysis: differential inhibitor production by an NK-resistant vs an NK-sensitive murine lymphoma. Chow DA Cell Immunol; 1990 Apr; 127(1):172-86. PubMed ID: 2317873 [TBL] [Abstract][Full Text] [Related]
15. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide. Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315 [TBL] [Abstract][Full Text] [Related]
16. Development of a murine lymphoma model system for the characterization of natural killer:tumor cell interactions. Smithson G; Wolcott RM; Chervenak R Cancer Res; 1992 Aug; 52(15):4149-56. PubMed ID: 1638530 [TBL] [Abstract][Full Text] [Related]
17. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain. Yamasaki T; Moritake K; Klein G J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434 [TBL] [Abstract][Full Text] [Related]
18. Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo. Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A Transplantation; 1978 Feb; 25(2):63-8. PubMed ID: 146282 [TBL] [Abstract][Full Text] [Related]
19. Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. Fioretti MC; Romani L; Bonmassar A; Taramelli D J Immunopharmacol; 1980; 2(2):189-212. PubMed ID: 6821551 [TBL] [Abstract][Full Text] [Related]
20. Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells. Marini S; Guadagni F; Bonmassar E; Potenza P; Giuliani A Cell Immunol; 1986 Oct; 102(1):113-25. PubMed ID: 3802199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]